DeepMed Research

Murdoch Childrens Research Institute

🇦🇺Australia

Country: 🇦🇺Australia

Ownership: Holding

Established: 1986-01-01

Employees: 1K

Market Cap: -

Website: http://www.mcri.edu.au

Clinical Trials

Preventing Young Infant Infections Using Azithromycin in Labour (PreYIAL) Trial

Phase 3

Completed

Conditions: Bacterial Infections

Interventions: Drug: Matching Placebo
Drug: Azithromycin 500 mg Oral Tablet x 4

First Posted Date: 2019-04-24

Last Posted Date: 2023-04-27

Lead Sponsor: Murdoch Childrens Research Institute

Target Recruit Count: 2110

Registration Number: NCT03925480

Locations: 🇫🇯
Colonial War Memorial Hospital and Mother and Child Health Clinics, Suva, Central, Fiji

What is the Incidence of an Immune Disorder in Children With Invasive Pneumococcal Disease (IPD)?

Completed

Conditions: Invasive Pneumococcal Disease, Recurrent Isolated, 1
Invasive Pneumococcal Disease, Recurrent Isolated, 2
Primary Immunodeficiency
Invasive Pneumococcal Disease, Protection Against

Interventions: Other: Referral to Immunology

First Posted Date: 2019-01-24

Last Posted Date: 2022-07-06

Lead Sponsor: Murdoch Childrens Research Institute

Target Recruit Count: 380

Registration Number: NCT03815357

Locations: 🇦🇺
Lady Cilento Children's Hospital, Brisbane, Australia
🇦🇺
Sydney Children's Hospital, Sydney, New South Wales, Australia
🇦🇺
Adelaide Women's and Children's Hospital, Adelaide, South Australia, Australia

and more 3 locations

Nitric Oxide During Bypass for Arterial Switch Operation

Phase 3

Completed

Conditions: Low Cardiac Output Syndrome
Transposition of Great Vessels

Interventions: Drug: Nitric Oxide

First Posted Date: 2018-09-07

Last Posted Date: 2024-04-18

Lead Sponsor: Murdoch Childrens Research Institute

Target Recruit Count: 300

Registration Number: NCT03661385

Locations: 🇦🇺
Royal Children's Hospital, Melbourne, Victoria, Australia
🇮🇩
Harapan Kita Children and Women's Hospital, Jakarta, Indonesia
🇨🇦
Stollery Cildren's Hospital, Edmonton, Alberta, Canada

and more 1 locations

A Phase II Dose-ranging Study of Oral RV3-BB Rotavirus Vaccine

Phase 2

Completed

Conditions: Rotavirus Infections

Interventions: Biological: RV3-BB
Biological: Placebo

First Posted Date: 2018-03-30

Last Posted Date: 2023-07-10

Lead Sponsor: Murdoch Childrens Research Institute

Target Recruit Count: 711

Registration Number: NCT03483116

Locations: 🇲🇼
Malawi-Liverpool-Wellcome Trust Clinical Research Programme, Blantyre, Malawi

Safety of Autologous Cord Blood Cells in HLHS Patients During Norwood Heart Surgery

Phase 1

Completed

Conditions: Heart Defects, Congenital
Hypoplastic Left Heart Syndrome
Pediatric Disorder

Interventions: Biological: Autologous Human Placental Cord Blood Mononuclear Cells

First Posted Date: 2018-02-13

Last Posted Date: 2022-07-22

Lead Sponsor: Murdoch Childrens Research Institute

Target Recruit Count: 10

Registration Number: NCT03431480

Locations: 🇦🇺
Royal Children's Hospital, Melbourne, Victoria, Australia

Can Vitamin D Treatment Help Treat Moderate to Severe Atopic Dermatitis in Young Children? The D-Vex Pilot Study

Phase 4

Terminated

Conditions: Atopic Dermatitis

Interventions: Drug: Stoss vitamin D
Drug: Daily vitamin D
Drug: Stoss placebo
Drug: Daily placebo

First Posted Date: 2017-08-22

Last Posted Date: 2025-03-14

Lead Sponsor: Murdoch Childrens Research Institute

Target Recruit Count: 13

Registration Number: NCT03257215

Locations: 🇦🇺
Royal Children's Hospital Melbourne, Melbourne, Victoria, Australia

Neurobehavioural Development of Infants Born <30 Weeks Gestational Age Between Birth and Five Years of Age

Completed

Conditions: Developmental Coordination Disorder
Preterm Infant
Neurodevelopmental Disorders
Motor Activity

First Posted Date: 2017-06-01

Last Posted Date: 2020-11-02

Lead Sponsor: Murdoch Childrens Research Institute

Target Recruit Count: 251

Registration Number: NCT03172104

Locations: 🇦🇺
Murdoch Childrens Research Institute, Parkville, Victoria, Australia

Trial of Simplified Pneumococcal Vaccination in Vietnam II

Phase 2

Completed

Conditions: Pneumococcal Vaccine

Interventions: Biological: PCV Vaccine

First Posted Date: 2017-04-04

Last Posted Date: 2024-11-27

Lead Sponsor: Murdoch Childrens Research Institute

Target Recruit Count: 2501

Registration Number: NCT03098628

Locations: 🇻🇳
Pasteur Institute, Ho Chi Minh City, Vietnam

A Study to Compare the Long-term Outcomes After Two Different Anaesthetics

Phase 3

Active, not recruiting

Conditions: Anesthesia
Child Development
Neurotoxicity

Interventions: Drug: Sevoflurane
Drug: Remifentanil
Drug: Dexmedetomidine

First Posted Date: 2017-03-24

Last Posted Date: 2024-07-05

Lead Sponsor: Murdoch Childrens Research Institute

Target Recruit Count: 450

Registration Number: NCT03089905

Locations: 🇺🇸
Boston Children's Hospital, Boston, Massachusetts, United States
🇺🇸
The University of Texas Southwestern Medical Center, Dallas, Texas, United States
🇺🇸
Cleveland Clinic, Cleveland, Ohio, United States

and more 18 locations

Stem Cells in Umbilical Blood Infusion for CP

Phase 1

Completed

Conditions: Cerebral Palsy

Interventions: Biological: Matched sibling donor cord blood cell infusion

First Posted Date: 2017-03-22

Last Posted Date: 2021-01-20

Lead Sponsor: Murdoch Childrens Research Institute

Target Recruit Count: 12

Registration Number: NCT03087110

Locations: 🇦🇺
Lady Cilento Children's Hospital, Brisbane, Queensland, Australia
🇦🇺
The Royal Children's Hospital, Melbourne, Victoria, Australia

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy